{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T14:27:15Z","timestamp":1725460035363},"publisher-location":"Boston","reference-count":21,"publisher":"Kluwer Academic Publishers","isbn-type":[{"type":"print","value":"0306477572"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/0-306-48382-3_83","type":"book-chapter","created":{"date-parts":[[2006,2,18]],"date-time":"2006-02-18T20:57:40Z","timestamp":1140296260000},"page":"405-412","source":"Crossref","is-referenced-by-count":0,"title":["The Influence of Plasma Fibrinogen and Serum Ferrum on Blood Viscosity in Adamantiades-Beh\u00e7et\u2019s Disease"],"prefix":"10.1007","author":[{"given":"S.","family":"Mineshita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Umezu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"83_CR1","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1128\/IAI.59.4.1434-1441.1991","volume":"59","author":"T. Lehner","year":"1991","unstructured":"Lehner, T., Lavery, E., Smith, R., et al., 1991, Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Beh\u00e7et\u2019s syndrome. Infect. Immun. 59: 1434\u20131441.","journal-title":"Infect. Immun."},{"key":"83_CR2","first-page":"361","volume-title":"Beh\u00e7et\u2019s Disease, Basic and Clinical Aspects","author":"M.C. Kabakci","year":"1991","unstructured":"Kabakci, M.C., Yucel, A.E., Saraclar, Y., et al., 1991, Serum total IgE levels in Beh\u00e7et\u2019s disease. In Beh\u00e7et\u2019s Disease, Basic and Clinical Aspects (J.D. O\u2019Duffy, and E. Kokmen, eds.), Marcel Decker, New York, pp. 361\u2013364."},{"key":"83_CR3","first-page":"128","volume":"24","author":"B. Turan","year":"1997","unstructured":"Turan, B., Gallati, H., G\u00fcrler A., et al., 1997, Systemic levels of the T cell regulatory cytokines IL-10 and Il-12 in Beh\u00e7et\u2019s disease; soluble TNFR-75 as a biological marker of disease activity. J. Rheumatol. 24: 128\u2013132.","journal-title":"J. Rheumatol."},{"key":"83_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s004030050219","volume":"289","author":"L.M. Wang","year":"1997","unstructured":"Wang, L.M., Kitteringham, N., Mineshita, S., et al., 1997, The demonstration of serum interleukin-8 and superoxide dismutase in Adamantiades-Beh\u00e7et\u2019s Disease. Arch. Dermatol. Res. 289: 444\u2013447.","journal-title":"Arch. Dermatol. Res."},{"key":"83_CR5","first-page":"155","volume-title":"Beh\u00e7et\u2019s disease, Basic and Clinical Aspects","author":"B. Wechsler","year":"1991","unstructured":"Wechsler, B., Vidaihel, M, Bousser, M.G., et al., 1991, Cerebral venous thrombosis in Beh\u00e7et\u2019s disease: Long-term follow-up of 21 cases. In Beh\u00e7et\u2019s disease, Basic and Clinical Aspects (J.D. O\u2019Duffy, and E. Kokmen, eds.), Marcel Decker, New York, pp. 155\u2013165."},{"key":"83_CR6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000018122","volume":"198","author":"A. Orem","year":"1999","unstructured":"Orem, A., Cimsit, G., Deger O., et al., 1999, Autoantibodies against oxidatively modified low-density lipoprotein in patients with Beh\u00e7et\u2019s disease. Dermatology 198: 243\u2013246.","journal-title":"Dermatology"},{"key":"83_CR7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/030006059802600405","volume":"26","author":"M. Nalcaci","year":"1998","unstructured":"Nalcaci, M., and Pekcelen, Y., 1998, Antithrombin III, protein C and protein S plasma levels in patients with Beh\u00e7et\u2019s disease. J. Int. Med. Res. 26: 206\u2013208.","journal-title":"J. Int. Med. Res."},{"key":"83_CR8","first-page":"127","volume-title":"Behcet\u2019s disease","author":"S. Guermazi","year":"1993","unstructured":"Guermazi, S., Hamza, M., and Dellagi, K., 1993, Protein S, thrombosis and Beh\u00e7et\u2019s disease. In Behcet\u2019s disease (B. Wechsler, and P. Godeau, eds.), Excerpta Medica, Amsterdam, pp. 127\u2013130."},{"key":"83_CR9","first-page":"59","volume-title":"Recent advances in Beh\u00e7et\u2019s disease","author":"P.S. Ramalho","year":"1986","unstructured":"Ramalho, P.S., Freitas, J.P., and Martins, R., 1986, Blood vicosity changes in Beh\u00e7et\u2019s disease. In Recent advances in Beh\u00e7et\u2019s disease (T. Lehner, and C.G. Barnes, eds.), Royal College of Medicine Services, London, pp. 59."},{"key":"83_CR10","first-page":"11","volume-title":"Annual report of Beh\u00e7et\u2019s disease Research Committee of Japan","year":"1987","unstructured":"Shimizu, T. (ed.), 1987, Annual report of Beh\u00e7et\u2019s disease Research Committee of Japan. Teikyo Pubication, Tokyo, pp. 11\u201317."},{"key":"83_CR11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/bmj.303.6803.605","volume":"303","author":"N. Qizilbash","year":"1991","unstructured":"Qizilbash, N., Jones, L., Warlow C., et al., 1991, Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes. Br. Med. J. 303: 605\u2013609.","journal-title":"Br. Med. J."},{"key":"83_CR12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/1047-2797(92)90095-8","volume":"2","author":"W.B. Kannel","year":"1992","unstructured":"Kannel, W.B., D\u2019Agostino, R.B., and Belanger, A.J., 1992, Update on fibrinogen as a cardiovascular risk factor. Ann. Epidemiol. 2: 457\u2013466.","journal-title":"Ann. Epidemiol."},{"key":"83_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0021-9150(93)90062-Y","volume":"100","author":"E. Ernst","year":"1993","unstructured":"Ernst, E., 1993, The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis 100: 1\u201312.","journal-title":"Atherosclerosis"},{"key":"83_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jcp.50.1.13","volume":"50","author":"T.W. Meade","year":"1997","unstructured":"Meade, T.W., 1997, Fibrinogen and cardiovascular disease. J. Clin. Pathol. 50: 13\u201315.","journal-title":"J. Clin. Pathol."},{"key":"83_CR15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0021-9150(98)00090-2","volume":"139","author":"A. Blann","year":"1988","unstructured":"Blann, A., Bignell, A., and McCollum, C., 1988, Von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity. Atherosclerosis 139: 317\u2013322.","journal-title":"Atherosclerosis"},{"key":"83_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0895-4356(99)00143-2","volume":"53","author":"E.S. Ford","year":"2000","unstructured":"Ford, E.S., and Giles, W.H., 2000, Serum c-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction. Findings from National Health and Nutrition Examination Survey III. J. Clin. Epidemiol. 53: 95\u2013102.","journal-title":"J. Clin. Epidemiol."},{"key":"83_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0021-9150(99)00240-3","volume":"148","author":"C. Held","year":"2000","unstructured":"Held, C., Hjemdahl, P., Wallen, N.H., et al., 2000, Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris \u2014 Results from the APSIS study. Atherosclerosis 148: 179\u2013188.","journal-title":"Atherosclerosis"},{"key":"83_CR18","first-page":"175","volume":"20","author":"H.L. Reid","year":"1999","unstructured":"Reid, H.L., and De Ceulaer, K., 1999, Abnormal plasma and serum viscosity in systemic lupus erythematosus (SLE): a Jamaican study. Clin. Hemorheol. Microcirculation 20: 175\u2013180.","journal-title":"Clin. Hemorheol. Microcirculation"},{"key":"83_CR19","first-page":"120","volume":"12","author":"S. Ohshima","year":"1998","unstructured":"Ohshima, S., Tagiguti, K., Tomooka, S., 1998, The effect of felodipine on the hemorheology and haemodynamic of the hypertension patients (Japanese). J. Jpn. Soc. Biorheol. 12: 120\u2013128.","journal-title":"J. Jpn. Soc. Biorheol."},{"key":"83_CR20","first-page":"35","volume":"13","author":"L.M. Wang","year":"1999","unstructured":"Wang, L.M., Yamamoto, T., Kuyama, Y., et al., 1999, The features of blood viscosity in cardiovascular disease (Japanese). J. Jpn. Soc. Biorheol. 13: 35\u201341.","journal-title":"J. Jpn. Soc. Biorheol."},{"key":"83_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000018426","volume":"201","author":"J. Katsantonis","year":"2000","unstructured":"Katsantonis, J., Adler, Y., Orfanos, C.E., et al., 2000, Adamantiades-Beh\u00e7et\u2019s disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology 201: 37\u201339.","journal-title":"Dermatology"}],"container-title":["Advances in Experimental Medicine and Biology","Adamantiades-Beh\u00e7et\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/0-306-48382-3_83.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T19:50:46Z","timestamp":1605642646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/0-306-48382-3_83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["0306477572"],"references-count":21,"URL":"https:\/\/doi.org\/10.1007\/0-306-48382-3_83","relation":{},"subject":[]}}